# BVF Partners: portfolio, investments and team > BVF Partners is a vc firm based in United States. 13 investments on record, 3 in the last 12 months, latest Oct 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/bvf-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # BVF Partners Last cheque observed Oct 2026; 13 cheques on record. Email Deploying now VC firm Series B Series A Series C Biotechnology Information Technology Follow BVF Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fbvf-partners) Deploying now **100%** of best year **3** **cheques in 12 months**, 13 on record Since the last cheque **2** days **00** hrs **00** min **00** sec Median round **$89M** Rounds led **2 of 13** Sole investor **1 rounds** Mostly in **United States, 100%** Pitch BVF Partners ## BVF Partners highlights - 01 3 cheques in the last 12 months - 02 Mostly Series B and Series A: 70% of its rounds - 03 Sole investor in 1 rounds, median $22M ## What they do - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Biotechnology Information Technology - **Based in:** United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **13 appearances** - **2026** 3 rounds - **Oct** **[Dren Bio](https://millionrounds.com/company/dren-bio)** US · Wowtale **$350M** With 13 others - **Sept** **[Caspian Therapeutics](https://millionrounds.com/company/caspian-therapeutics)** Series A · QRM Capital **$50M** *Led* - **Jun** **[Contraline](https://millionrounds.com/company/contraline)** Series B · Ventureburn **$93M** *Led* - **2019** 4 rounds - **Dec** **[Black Diamon Therapeutics](https://millionrounds.com/company/black-diamon-therapeutics)** Series C · US · FinSMEs **$85M** With 6 others - **May** **[Phathom Pharmaceuticals](https://millionrounds.com/company/phathom-pharmaceuticals)** US · FinSMEs **$140M** With 8 others - **Apr** **[SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics)** Series B · US · FinSMEs **$125M** With 12 others - **Mar** **[Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics)** Series B · US · Medcitynews **$50M** With 10 others - **2018** 4 rounds - **Dec** **[Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics)** Series B · US · FinSMEs **$70M** With 9 others - **Aug** **[Protagonist Therapeutics](https://millionrounds.com/company/protagonist-therapeutics)** US · FinSMEs **$22M** Sole investor - **Mar** **[Ideaya](https://millionrounds.com/company/ideaya)** Series B · US · FinSMEs **$94M** With 12 others - **Mar** **[Prevail](https://millionrounds.com/company/prevail)** Series A · FinSMEs **$75M** With 8 others - **2017** 1 round - **Nov** **[Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences)** Series C · US · Businesswire **$107M** With 5 others - **2015** 1 round - **Jul** **[AnaptysBio](https://millionrounds.com/company/anaptysbio)** Series D · US **$40M** With 4 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The cheque Series B Series A Series C Median round joined **$89M** the round, not its cheque Alone, median **$22M** Led 2 of 13 rounds **15%** - **Sole investor:** 1 rounds - **Last cheque:** Oct 2026 Rounds by stage said on their site - Series B *5* - Series A *2* - Series C *2* - Series D *1* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Boxer Capital](https://millionrounds.com/fund/boxer-capital) 6 - [OrbiMed](https://millionrounds.com/fund/orbimed) 4 - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 3 - [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) 3 - [ArrowMark Partners](https://millionrounds.com/fund/arrowmark-partners) 2 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 2 **Pitching BVF Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as BVF Partners. A count of rooms they were both in, not a relationship either has claimed. [**Boxer Capital** VC firm **6** rounds together](https://millionrounds.com/fund/boxer-capital)[**OrbiMed** Private equity **4** rounds together](https://millionrounds.com/fund/orbimed)[**Alexandria Real Estate Equities** VC firm **3** rounds together](https://millionrounds.com/fund/alexandria)[**EcoR1 Capital** Private equity **3** rounds together](https://millionrounds.com/fund/ecor1-capital)[**ArrowMark Partners** Private equity **2** rounds together](https://millionrounds.com/fund/arrowmark-partners)[**Cormorant Asset Management** Private equity **2** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Frazier Healthcare Partners** Private equity **2** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Google Ventures** Corporate VC **2** rounds together](https://millionrounds.com/fund/gv)[**Invus** Private equity **2** rounds together](https://millionrounds.com/fund/invus)[**Janus Henderson Investors** Private equity **2** rounds together](https://millionrounds.com/fund/janus-henderson-investors)[**Omega Funds** VC firm **2** rounds together](https://millionrounds.com/fund/omega-funds)[**Perceptive Advisors** Asset manager **2** rounds together](https://millionrounds.com/fund/perceptive-advisors) ## Recently backed The latest companies BVF Partners put money into. [**Dren Bio** $350M · Oct 2026](https://millionrounds.com/company/dren-bio)[**Contraline** $93M · Jun 2026](https://millionrounds.com/company/contraline)[**Phathom Pharmaceuticals** $140M · May 2019](https://millionrounds.com/company/phathom-pharmaceuticals)[**SpringWorks Therapeutics** $125M · Apr 2019](https://millionrounds.com/company/springworks-therapeutics)[**Akero Therapeutics** $70M · Dec 2018](https://millionrounds.com/company/akero-therapeutics)[**Protagonist Therapeutics** $22M · Aug 2018](https://millionrounds.com/company/protagonist-therapeutics) ## Quick answers about BVF Partners ### What does BVF Partners invest in? BVF Partners invests most often at Series B and Series A (70% of the rounds on record), in sectors such as Biotechnology and Information Technology. ### How active is BVF Partners? 13 investments on record, 3 of them in the last 12 months, and it led 2. The most recent was in Oct 2026. ### What has BVF Partners invested in recently? Its most recent investments on record: Dren Bio (Undisclosed round, Oct 2026), Caspian Therapeutics (Series A, Sept 2026) and Contraline (Series B, Jun 2026). ### How big are BVF Partners's cheques? The median round it joins is $89M. ### Does BVF Partners lead rounds? Yes: it led 2 of its 13 investments on record (15%). ### Where does BVF Partners invest? Most of the companies it backs are in the United States (100%). ### Is BVF Partners investing now? Yes: it is actively investing, with 3 investments in the last 12 months. ### Who does BVF Partners invest alongside? Most often Boxer Capital (6 rounds together), OrbiMed (4 rounds together) and Alexandria Real Estate Equities (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=bvf-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=bvf-partners)